William D Barbo Charles River Laboratories International, Inc. (CRL) insider trading activity

William D Barbo is Corporate Executive VP & CCO of CHARLES RIVER LABORATORIES INTERNATIONAL, INC.. Currently has a direct ownership of 3,433 shares of CRL, which is worth approximately $739,433. The most recent transaction as insider was on May 29, 2024, when has been sold 179 shares (Common Stock) at a price of $214.51 per share, resulting in proceeds of $38,397. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3.43K

0% 3M change

4.43% 12M change

Total Value Held $739,433

William D Barbo Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 29 2024	SELL Payment of exercise price or tax liability	$38,397 $214.51 p/Share	179 Reduced 4.96%	3,433 Common Stock
May 28 2024	SELL Payment of exercise price or tax liability	$18,245 $217.21 p/Share	84 Reduced 2.28%	3,605 Common Stock
May 27 2024	SELL Payment of exercise price or tax liability	$28,671 $217.21 p/Share	132 Reduced 3.45%	3,689 Common Stock
May 26 2024	SELL Payment of exercise price or tax liability	$38,446 $217.21 p/Share	177 Reduced 4.43%	3,821 Common Stock
Jan 29 2024	SELL Payment of exercise price or tax liability	$169,615 $220.28 p/Share	770 Reduced 6.36%	11,330 Common Stock
Jan 29 2024	BUY Grant, award, or other acquisition	-	2,997 Added 19.85%	12,100 Common Stock
Aug 10 2023	SELL Open market or private sale	$1,251,954 $217.24 p/Share	5,763 Reduced 61.6%	3,592 Common Stock
Aug 10 2023	BUY Exercise of conversion of derivative security	$797,276 $144.67 p/Share	5,511 Added 37.71%	9,103 Common Stock
May 29 2023	SELL Payment of exercise price or tax liability	$39,212 $194.12 p/Share	202 Reduced 1.99%	9,954 Common Stock
May 28 2023	SELL Payment of exercise price or tax liability	$21,741 $194.12 p/Share	112 Reduced 1.09%	10,156 Common Stock
May 27 2023	SELL Payment of exercise price or tax liability	$32,223 $194.12 p/Share	166 Reduced 1.59%	10,268 Common Stock
May 26 2023	BUY Grant, award, or other acquisition	-	1,958 Added 15.8%	10,434 Common Stock
Feb 22 2023	SELL Payment of exercise price or tax liability	$69,913 $243.6 p/Share	287 Reduced 3.28%	8,476 Common Stock
Jan 27 2023	SELL Payment of exercise price or tax liability	$707,708 $244.29 p/Share	2,897 Reduced 24.85%	8,763 Common Stock
Jan 27 2023	BUY Grant, award, or other acquisition	-	7,857 Added 40.26%	11,660 Common Stock
Dec 02 2022	SELL Open market or private sale	$704,234 $219.73 p/Share	3,205 Reduced 45.73%	3,803 Common Stock
Dec 02 2022	BUY Exercise of conversion of derivative security	$350,434 $109.34 p/Share	3,205 Added 31.38%	7,008 Common Stock
Jun 07 2022	SELL Bona fide gift	-	391 Reduced 9.32%	3,803 Common Stock
May 29 2022	SELL Payment of exercise price or tax liability	$49,371 $244.41 p/Share	202 Reduced 4.6%	4,194 Common Stock
May 28 2022	SELL Payment of exercise price or tax liability	$27,374 $244.41 p/Share	112 Reduced 2.48%	4,396 Common Stock
May 27 2022	BUY Grant, award, or other acquisition	-	1,493 Added 24.88%	4,508 Common Stock
Mar 11 2022	SELL Bona fide gift	-	754 Reduced 20.01%	3,015 Common Stock
Feb 23 2022	SELL Payment of exercise price or tax liability	$91,218 $289.58 p/Share	315 Reduced 7.71%	3,769 Common Stock
Feb 22 2022	SELL Payment of exercise price or tax liability	$84,266 $293.61 p/Share	287 Reduced 6.57%	4,084 Common Stock
Feb 08 2022	SELL Bona fide gift	-	6,178 Reduced 58.56%	4,371 Common Stock

WDB

William D Barbo

Corporate Executive VP & CCO

Wilmington, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CRL shares.

Notify only if

Value

Insider Trading

Get notified when an Charles River Laboratories International, Inc. insider buys or sells CRL shares.

Notify only if

Operation

Value

Type

News

Receive news related to CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Track Activities on CRL

Account